<PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">39454205</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>25</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2473-9537</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2024</Year><Month>Oct</Month><Day>25</Day></PubDate></JournalIssue><Title>Blood advances</Title><ISOAbbreviation>Blood Adv</ISOAbbreviation></Journal><ArticleTitle>COVID-19 in patients with Chronic Lymphocytic Leukemia treated with venetoclax: what is the role of anti-CD20 antibody?</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">bloodadvances.2024013792</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1182/bloodadvances.2024013792</ELocationID><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Autore</LastName><ForeName>Francesco</ForeName><Initials>F</Initials><Identifier Source="ORCID">0000-0002-7868-7469</Identifier><AffiliationInfo><Affiliation>Fondazione Policlinico A. Gemelli IRCCS, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Visentin</LastName><ForeName>Andrea</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Hematology Unit, Department of Medicine, University of Padova, Padova, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Deodato</LastName><ForeName>Marina</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>ASST Grande Ospedale Metropolitano Niguarda, Niguarda Cancer Center, Milano, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vitale</LastName><ForeName>Candida</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0002-2592-8724</Identifier><AffiliationInfo><Affiliation>Univeristy of Torino, Torino, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Galli</LastName><ForeName>Eugenio</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Fondazione Policlinico Universitario Agostino Gemelli-IRCCS, Rome, Idaho, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fresa</LastName><ForeName>Alberto</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-8084-9009</Identifier><AffiliationInfo><Affiliation>Hematology-Oncology and Stem-Cell Transplantation Unit, Department of Onco-Hematology and Innovative Diagnostics, Istituto Nazionale Tumori IRCCS - Fondazione "G. Pascale", Naples, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fazzi</LastName><ForeName>Rita</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Hematology Unit - A.O.U.P. Ospedale Santa Chiara, Pisa, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sanna</LastName><ForeName>Alessandro</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>AOU Careggi, Florence, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Olivieri</LastName><ForeName>Jacopo</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>ASUFC, Udine, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Scortechini</LastName><ForeName>Ilaria</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Ospedali Riuniti Ancona.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Del Principe</LastName><ForeName>Maria Ilaria</ForeName><Initials>MI</Initials><AffiliationInfo><Affiliation>UOC Ematologia Tor Vergata, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sportoletti</LastName><ForeName>Paolo</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>University of Perugia, Perugia, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Innocenti</LastName><ForeName>Idanna</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Fondazione Policlinico Universitario A. Gemelli, IRCCS, Roma, Italy, roma, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Coscia</LastName><ForeName>Marta</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0003-2123-7675</Identifier><AffiliationInfo><Affiliation>University of Torino, Torino, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tedeschi</LastName><ForeName>Alessandra</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>ASST Grande Ospedale Metropolitano Niguarda, Niguarda Cancer Center, Milano, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Trentin</LastName><ForeName>Livio</ForeName><Initials>L</Initials><Suffix>Prof</Suffix><Identifier Source="ORCID">0000-0003-1222-6149</Identifier><AffiliationInfo><Affiliation>University of Padua, PADOVA, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Candoni</LastName><ForeName>Anna</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Dept. of Medical and Surgical Sciences University of Modena and Reggio Emilia, MODENA, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Busca</LastName><ForeName>Alessandro</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>A.O.U. Citt√† della Salute e della Scienza, Turin, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pagano</LastName><ForeName>Livio</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0001-8287-928X</Identifier><AffiliationInfo><Affiliation>Hematology, Fondazione Policlinico Universitario Agostino Gemelli - IRCCS, Rome, Italy, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Laurenti</LastName><ForeName>Luca</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0002-8327-1396</Identifier><AffiliationInfo><Affiliation>Fondazione Policlinico Universitario A Gemelli Roma IRCCS, roma, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>25</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Blood Adv</MedlineTA><NlmUniqueID>101698425</NlmUniqueID><ISSNLinking>2473-9529</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>5</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>9</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>25</Day><Hour>18</Hour><Minute>22</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>25</Day><Hour>18</Hour><Minute>22</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>25</Day><Hour>17</Hour><Minute>22</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39454205</ArticleId><ArticleId IdType="doi">10.1182/bloodadvances.2024013792</ArticleId><ArticleId IdType="pii">525799</ArticleId></ArticleIdList></PubmedData></PubmedArticle>